Bete, Baby Boy B.
HRN: 28-90-18 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/22/2026
CEFOTAXIME 500MG (VIAL)
04/22/2026
04/29/2026
IV
350mg
Q8H
Scald Burn
Checking Initial Appropriateness
04/22/2026
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
04/22/2026
04/29/2026
TOPICAL
1%
BID
Scald Burn
Checking Initial Appropriateness
04/23/2026
CEFUROXIME 750MG (VIAL)
04/23/2026
04/30/2026
IV
350mg
Q8h
Scald Burn
Checking Initial Appropriateness
04/27/2026
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
04/27/2026
05/03/2026
TOPICAL
Pea Size
OD
Superficial Partial Thickness Burn
Checking Initial Appropriateness